slide image

TrueVue ODM+ is the world’s first fluid management and cardiac output monitoring system to measure both flow and pressure directly.

slide image

COVID-19 case presentation points to importance of understanding haemodynamic status

slide image

Acute Kidney Injury avoidance and the role of haemodynamic management

Latest news:

23rd ODM+ RCT shows benefit in Obese Patients

A newly published randomised controlled trial (RCT) is the 23rd to reinforce the important contribution of oesophageal Doppler monitoring (ODM+). The study evaluates haemodynamic management in obese surgical patients. Obesity... read more

Haemodynamic Management improves patients’ safety

“In the United States, at least $5 billion in hospital costs are related to AKI, and the true costs are likely much, much higher.” Silver et al, Nephron 2017;137:297–301

ODM has been used in more than 1 million surgical and ICU patients globally

Quick and easy to use

Significantly reduces the annual global cost of treating surgical AKI

Implementation costs can be recouped by avoiding an AKI in fewer than 5 patients haemodynamically optimised

Deltex Medical Limited

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:
    Apple App Store LogoGoogle Play Store Logo

 

Registered in England & Wales Company No: 1691369
∧